<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031208</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2016/0786</org_study_id>
    <nct_id>NCT05031208</nct_id>
  </id_info>
  <brief_title>Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy</brief_title>
  <official_title>Research on the Acute and Long Term Effects on Memory and the Mechanism of Action of Vagus Nerve Stimulation in Patients With Refractory Epilepsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Refractory epilepsy patients implanted with a vagus nerve stimulator perform a memory test at&#xD;
      baseline in three conditions: invasive vagus nerve stimulation (VNS), transcutaneous vagus&#xD;
      nerve stimulation (taVNS) and sham stimulation. After 6 weeks of VNS treatment, the memory&#xD;
      test is repeated in two condition: invasive vagus nerve stimulation (VNS) and sham&#xD;
      stimulation.&#xD;
&#xD;
      The endpoint of this experiment is assessing the effect of VNS and taVNS on memory&#xD;
      performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies underlined the potential of both invasive as transcutaneous auricular vagus&#xD;
      nerve stimulation to ameliorate certain cognitive functions.&#xD;
&#xD;
      In this randomized, controlled cross-over within-subjects study, a memory test is conducted&#xD;
      in patients with refractory epilepsy who are implanted with a vagus nerve stimulation.&#xD;
&#xD;
      The memory test consists out of a word recognition paradigm based on the study of Clarck et&#xD;
      al. published in 1999 in Nature Neuroscience. Testing is performed at baseline (before start&#xD;
      of the stimulation) and after 6 weeks of treatment with vagus nerve stimulation.&#xD;
&#xD;
      During the first session, the patients complete the word recognition task during three&#xD;
      interventions:&#xD;
&#xD;
        -  Invasive vagus nerve stimulation&#xD;
&#xD;
        -  Transcutaneous vagus nerve stimulation (cymba concha)&#xD;
&#xD;
        -  Sham vagus nerve stimulation (no stimulation)&#xD;
&#xD;
      During the second session, the patients complete the word recognition task during two&#xD;
      interventions:&#xD;
&#xD;
        -  Invasive vagus nerve stimulation&#xD;
&#xD;
        -  Sham vagus nerve stimulation (no stimulation)&#xD;
&#xD;
      The goal is to investigate if invasive vagus nerve stimulation and transcutaneous nerve&#xD;
      stimulation can influence (i.e. improve) the performance on the memory task and if this&#xD;
      performance is improved after 6 weeks of VNS treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 22, 2018</start_date>
  <completion_date type="Actual">August 28, 2020</completion_date>
  <primary_completion_date type="Actual">August 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immediate recall score at session 1</measure>
    <time_frame>At baseline</time_frame>
    <description>Free recall score for correctly recalled words (min score 0,max score 21, higher score indicates better performance), calculated as a percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Immediate recall score at session 2</measure>
    <time_frame>After 6 weeks of VNS treatment</time_frame>
    <description>Free recall score for correctly recalled words (min score 0, max score 21, higher score indicates better performance)), calculated as a percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delayed recognition scores at session 1</measure>
    <time_frame>At baseline</time_frame>
    <description>Hitscore for correctly recognized target words (min score 0,max score 63, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 63, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 63, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 63, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 63, higher score indicates better performance). All scores are calculated as a percentage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Delayed recognition scores at session 2</measure>
    <time_frame>After 6 weeks of VNS treatment</time_frame>
    <description>Hitscore for correctly recognized target words (min score 0,max score 48, higher score indicates better performance), score for not recognized target words= misses (min score 0,max score 48, higher score indicates worse performance),correct rejection score of non-target related words (min score 0,max score 48, higher score indicates better performance), score for incorrect recognition of non-target related words= false alarms (min score 0,max score 48, higher score indicates worse performance), discrimination index= hit score -false alarm score (min score 0,max score 48, higher score indicates better performance). All scores are calculated as a percentage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attention score at session 1</measure>
    <time_frame>At baseline</time_frame>
    <description>Score of correct responses on 6 open question (min score 0, max score 6, higher score indicates better performance), calculated as a percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attention score at session 2</measure>
    <time_frame>After 6 weeks of VNS treatment</time_frame>
    <description>Score of correct responses on 6 open question (min score 0, max score 6, higher score indicates better performance), calculated as a percentage</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Refractory Epilepsy</condition>
  <arm_group>
    <arm_group_label>Vagus nerve stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Invasive vagus nerve stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcutaneous vagus nerve stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cymba concha stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham vagus nerve stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No vagus nerve stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Memory task</intervention_name>
    <description>Word recognition task</description>
    <arm_group_label>Sham vagus nerve stimulation</arm_group_label>
    <arm_group_label>Transcutaneous vagus nerve stimulation</arm_group_label>
    <arm_group_label>Vagus nerve stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Refractory epilepsy&#xD;
&#xD;
          -  Treated with vagus nerve stimulation&#xD;
&#xD;
          -  IQ &gt;= 70 and able to perform the memory task&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  IQ &lt; 70&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci. 1999 Jan;2(1):94-8.</citation>
    <PMID>10195186</PMID>
  </reference>
  <reference>
    <citation>Jacobs HI, Riphagen JM, Razat CM, Wiese S, Sack AT. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol Aging. 2015 May;36(5):1860-7. doi: 10.1016/j.neurobiolaging.2015.02.023. Epub 2015 Feb 28.</citation>
    <PMID>25805212</PMID>
  </reference>
  <reference>
    <citation>Colzato LS, Ritter SM, Steenbergen L. Transcutaneous vagus nerve stimulation (tVNS) enhances divergent thinking. Neuropsychologia. 2018 Mar;111:72-76. doi: 10.1016/j.neuropsychologia.2018.01.003. Epub 2018 Jan 8.</citation>
    <PMID>29326067</PMID>
  </reference>
  <reference>
    <citation>Steenbergen L, Sellaro R, Stock AK, Verkuil B, Beste C, Colzato LS. Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during action cascading processes. Eur Neuropsychopharmacol. 2015 Jun;25(6):773-8. doi: 10.1016/j.euroneuro.2015.03.015. Epub 2015 Mar 30.</citation>
    <PMID>25869158</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Ghent</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Kristl Vonck</investigator_full_name>
    <investigator_title>Prof. dr. Kristl Vonck</investigator_title>
  </responsible_party>
  <keyword>Vagus nerve stimulation</keyword>
  <keyword>Transcutaneous vagus nerve stimulation</keyword>
  <keyword>Word recognition paradigm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

